Mehmet Bilici

Mehmet Bilici

Auto-generated profile, based on publicly available information

Mehmet Bilici

Ataturk University, Faculty of Medicine, Erzurum, Turkey

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2009 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
HDHakan Dursun
Hakan Dursun
MBMehmet Bilici
Mehmet Bilici
FAFatih Albayrak
Fatih Albayrak
COCengiz Ozturk
Cengiz Ozturk
MSMustafa B Saglam
Mustafa B Saglam
HSHalis Suleyman
Halis Suleyman
Background: Although many drugs are available for the treatment of gastric ulcers, often these drugs are ineffective. Many antidepressant drugs have been shown to have antiulcer activity in various models of experimental ulcer. One such drug, the antidepressant mirtazapine, has been reported to have an antiulcer effect that involves an increase in antioxidant, and a decrease in oxidant, parameters. To date, however, there is no information available regarding the antiulcer activity for a similar antidepressant, fluvoxamine. This study aimed to investigate the antiulcer effects of fluvoxamine and to determine its relationship with antioxidants. Methods: Groups of rats fasted for 24 h received fluvoxamine (25, 50, 100 and 200 mg/kg), ranitidine (50 mg/kg) or distilled water by oral gavage. Indomethacin (25 mg/kg) was orally administered to the rats as an ulcerative agent. Six hours after ulcer induction, the stomachs of the rats were excised and an ulcer index determined. Separate groups of rats were treated with the same doses of fluvoxamine and ranitidine, but not with indomethacin, to test effects of these drugs alone on biochemical parameters. The stomachs were evaluated biochemically to determine oxidant and antioxidant parameters. We used one-way ANOVA and least significant difference (LSD) options for data analysis. Results: The 25, 50, 100 and 200 mg/kg doses of fluvoxamine exerted antiulcer effects of 48.5, 67.5, 82.1 and 96.1%, respectively, compared to the control rat group. Ranitidine showed an 86.5% antiulcer effect. No differences were observed in the absence of indomethacin treatment for any dose of fluvoxamine or for ranitidine. The levels of antioxidant parameters, total glutathione and nitric oxide, were increased in all fluvoxamine groups and in the ranitidine group when compared with the indomethacin-only group. In addition, fluvoxamine and ranitidine decreased the levels of the oxidant parameters, myeloperoxidase and malondialdeyhyde, in the stomach tissues of the rats when compared to indomethacin group. Conclusion: We conclude that fluvoxamine has antiulcer effects, and that these occur by a mechanism that involves activation of antioxidant parameters and inhibition of some toxic oxidant parameters.

31 October 2012 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
MBMehmet Bilici
Mehmet Bilici
KCKerim Cayir
Kerim Cayir
STSalim Basol Tekin
Salim Basol Tekin
CGCemal Gundogdu
Cemal Gundogdu
AAAbdulmecit Albayrak
Abdulmecit Albayrak
HSHalis Suleyman
Halis Suleyman
Effect of Mirtazapine on MNNG-Induced Gastric Adenocarcinoma in Rats Gastric cancer;rat;MNNG;mirtazapine;cisplatin;prevention; Objective: In this study, anticancer effects of mirtazapine on rats were investigated in an adenocarcinoma model induced by N-methyl-N-nitro-N-nitrosoguanidine (MNNG) and compared with those of cisplatin. Materials and Methods: For this purpose, 10 mg/kg doses of mirtazapine were administered orally to one group of rats, while 1 mg/kg doses of cisplatin were administered intraperitoneally to another group. At 1 hour after administration, 200 mg/kg doses of MNNG were given orally to both groups. MNNG administration was repeated once every 10 days through 3 months, after which period, gastric tissue was taken and pathologically evaluated. Results: Mirtazapine prevented adenocarcinoma induction by MNNG in rats to a greater extent than cisplatin. Some of the rats receiving cisplatin demonstrated severe dysplasia in gastric samples and others exhibited mild dysplasia. Rats given mirtazapine were not observed to suffer severe dysplasia, only mild dysplasia being observed. Conclusion: For adenocarcinoma induced by MNNG on rats, mirtazapine was determined more effective than cisplatin. In order to make statement about mechanism of anticancer activity of mirtazapine, wider studies are required.

12 October 2010 in Electronic Journal of General Medicine
Verified
Journal Article
Open access
KÇKerim Çayır
Kerim Çayır
MBMehmet Bilici
Mehmet Bilici
STSalim Başol Tekin
Salim Başol Tekin
FKFatih Kara
Fatih Kara
ATAtilla Turkyılmaz
Atilla Turkyılmaz
AYAbdülkadir Yıldırım
Abdülkadir Yıldırım

2 March 2012 in Hepatogastroenterology
Verified
Journal Article
Closed access
MKMehmet Kucukoner
Mehmet Kucukoner
AIAbdurrahmen Isikdogan
Abdurrahmen Isikdogan
EAErkan Arpaci
Erkan Arpaci
MBMehmet Bilici
Mehmet Bilici
DUDoğan Uncu
Doğan Uncu
SBSuleyman Buyukberber
Suleyman Buyukberber
The aims of this study were to report the clinical outcomes of adjuvant chemo-radiotherapy after curative resection in 637 patients with gastric cancer. The retrospective analysis included 637 patients with resectable gastric cancer and stage IB-IV (M0) from 8 medical centers between 2003 and 2010. The patients were treated with 5FU-leucovorin and radiotherapy according to Schema for INT-0116. Of the 637 patients, the median of overall survival (OS) was 43.7 months and relapse free survival (RFS) was 36.6 months. OS rates were 84%, 45%, 40% while RFS rates were 81%, 45% and 35% at 1, 3 and 5-years, respectively. Hematological and gastrointestinal toxicities (grade 1-4) were observed in 35% and 36.5% of patients, respectively. In univariate analysis, according to the Lauren classification, tumor grade, T stage, N stage, type of operation (total gastrectomy or subtotal) and surgery resection margin (R0 or R1) were found as prognostic factors on RFS and OS (p<0.05). In multivariate analysis, T stage, N stage and surgical margins were found as effective factors on OS. T stage, N stage and Lauren classification were factors affecting RFS. Adjuvant chemo-radiotherapy after curative resection of gastric cancer was feasible, with acceptable toxicities in the Turkish population.

1 April 2010 in The Eurasian Journal of Medicine
Verified
Journal Article
Closed access
MBMehmet Bilici
Mehmet Bilici
NONihat Okcu
Nihat Okcu
KCKerim Cayir
Kerim Cayir
IPIbrahim Pirim
Ibrahim Pirim
STSalim B. Tekin
Salim B. Tekin
CGCemal Gundogdu
Cemal Gundogdu
Gastric cancer is an important disease that is seen all over the world and that threats public health. At the same time, gastric cancer is a heterogeneous disorder with multifactorial etiologies. Recent studies have shown a significant association between HLA antigens and gastric adenocarcinoma. The aim of the present study was to determine the distribution of HLA class I (HLA-A, B and C) and class II (HLA-DR, DQ and DP) antigens in Turkish patients with gastric adenocarcinoma. HLA alleles or HLA haplotypes associated with gastric cancer were established in the Turkish population using PSR-SSP analysis in 71 unrelated patients with gastric cancer and in 82 unrelated healthy controls. The statistical significance of differences in allele frequencies between patients and controls was measured by the Chi-square test with Yates's correction. The study revealed that the HLA-Cw5 antigen is more prevalent in patients with gastric cancer (p=0.042) and that the HLA-DRB1*15 antigen is more prevelent in the control group (p=0.021). It is probable that HLA-Cw5 is a risk factor for gastric cancer whereas HLA-DRB1*15 plays a protective role for this disease. The results show that different loci on HLA may control resistance to or tendency for any disease in different societies; each society should determine its own tissue group.

31 May 2009 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
MAMehmet Dumlu Aydin
Mehmet Dumlu Aydin
MBMehmet Bilici
Mehmet Bilici
AEAttila Eroglu
Attila Eroglu
ATAttila Turkyilmaz
Attila Turkyilmaz
CGCemal Gundogdu
Cemal Gundogdu